Thomas and Massague revealed that the TGF-β/Smad pathway could directly bind to their promoter regions to downregulate the expression of granzyme B and IFN-γ (Thomas and Massague, 2005), which are responsible for cytotoxic T-lymphocyte-mediated tumor cytotoxicity. Here, TGFB1 is linked to neoplasm.